213 related articles for article (PubMed ID: 21559804)
1. delta(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory.
Wise LE; Varvel SA; Selley DE; Wiebelhaus JM; Long KA; Middleton LS; Sim-Selley LJ; Lichtman AH
Psychopharmacology (Berl); 2011 Oct; 217(4):485-94. PubMed ID: 21559804
[TBL] [Abstract][Full Text] [Related]
2. SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice.
Da S; Takahashi RN
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):321-5. PubMed ID: 11817511
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
Wise LE; Thorpe AJ; Lichtman AH
Neuropsychopharmacology; 2009 Aug; 34(9):2072-80. PubMed ID: 19322169
[TBL] [Abstract][Full Text] [Related]
4. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.
Stewart JL; McMahon LR
J Pharmacol Exp Ther; 2010 Jul; 334(1):347-56. PubMed ID: 20375197
[TBL] [Abstract][Full Text] [Related]
5. Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice.
Trexler KR; Nass SR; Crowe MS; Gross JD; Jones MS; McKitrick AW; Siderovski DP; Kinsey SG
Drug Alcohol Depend; 2018 Oct; 191():14-24. PubMed ID: 30071445
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of learning and memory impairment induced by delta9-tetrahydrocannabinol in rats.
Mishima K; Egashira N; Hirosawa N; Fujii M; Matsumoto Y; Iwasaki K; Fujiwara M
Jpn J Pharmacol; 2001 Dec; 87(4):297-308. PubMed ID: 11829149
[TBL] [Abstract][Full Text] [Related]
7. JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.
Ginsburg BC; Schulze DR; Hruba L; McMahon LR
J Pharmacol Exp Ther; 2012 Jan; 340(1):37-45. PubMed ID: 21965552
[TBL] [Abstract][Full Text] [Related]
8. Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice.
Wise LE; Long KA; Abdullah RA; Long JZ; Cravatt BF; Lichtman AH
ACS Chem Neurosci; 2012 May; 3(5):369-78. PubMed ID: 22860205
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice.
Schlosburg JE; Carlson BL; Ramesh D; Abdullah RA; Long JZ; Cravatt BF; Lichtman AH
AAPS J; 2009 Jun; 11(2):342-52. PubMed ID: 19430909
[TBL] [Abstract][Full Text] [Related]
10. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
[TBL] [Abstract][Full Text] [Related]
11. Antagonist-elicited cannabis withdrawal in humans.
Gorelick DA; Goodwin RS; Schwilke E; Schwope DM; Darwin WD; Kelly DL; McMahon RP; Liu F; Ortemann-Renon C; Bonnet D; Huestis MA
J Clin Psychopharmacol; 2011 Oct; 31(5):603-12. PubMed ID: 21869692
[TBL] [Abstract][Full Text] [Related]
12. Differential disruption of response alternation by precipitated Δ
Eckard ML; Kinsey SG
Pharmacol Biochem Behav; 2024 Mar; 236():173718. PubMed ID: 38272272
[TBL] [Abstract][Full Text] [Related]
13. Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline.
Varvel SA; Anum E; Niyuhire F; Wise LE; Lichtman AH
Psychopharmacology (Berl); 2005 Mar; 178(2-3):317-27. PubMed ID: 15322725
[TBL] [Abstract][Full Text] [Related]
14. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.
Lichtman AH; Fisher J; Martin BR
Pharmacol Biochem Behav; 2001; 69(1-2):181-8. PubMed ID: 11420084
[TBL] [Abstract][Full Text] [Related]
15. Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze.
Huang P; Liu-Chen LY; Kirby LG
Neurosci Lett; 2010 May; 475(3):165-8. PubMed ID: 20363293
[TBL] [Abstract][Full Text] [Related]
16. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
Lichtman AH; Sheikh SM; Loh HH; Martin BR
J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
[TBL] [Abstract][Full Text] [Related]
17. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.
Ghozland S; Matthes HW; Simonin F; Filliol D; Kieffer BL; Maldonado R
J Neurosci; 2002 Feb; 22(3):1146-54. PubMed ID: 11826143
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum.
Tzavara ET; Valjent E; Firmo C; Mas M; Beslot F; Defer N; Roques BP; Hanoune J; Maldonado R
Eur J Neurosci; 2000 Mar; 12(3):1038-46. PubMed ID: 10762335
[TBL] [Abstract][Full Text] [Related]
19. Precipitated Δ9-THC withdrawal reduces motivation for sucrose reinforcement in mice.
Eckard ML; Trexler KR; Kotson BT; Anderson KG; Kinsey SG
Pharmacol Biochem Behav; 2020 Aug; 195():172966. PubMed ID: 32526216
[TBL] [Abstract][Full Text] [Related]
20. Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism.
Lichtman AH; Martin BR
Psychopharmacology (Berl); 1996 Jul; 126(2):125-31. PubMed ID: 8856831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
